Tech Company Financing Transactions
BioEclipse Therapeutics Funding Round
Revelis Capital, DEFTA Partners and Foothill Ventures participated in a $7.7 million Series A funding round for BioEclipse Therapeutics. The round was announced on 6/25/2019.
Revelis Capital (Lead Investor) (Oliver Hopkinson)
San Francisco, CA 94080
Browse more venture capital transactions:
Prev: 6/25/2019: Alma venture capital transaction
Next: 6/25/2019: Corinth MedTech venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs